FOR IMMEDIATE RELEASE FDA EXTENDS MARKETING EXCLUSIVITY FOR INOMAX® Clinton, NJ, January 5, 2011– Ikaria, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted INOMAX® (nitric oxide) for i

First Page		Document Content
Date: 2011-06-28 11:53:07 Intensive care medicine Hypertension Neurotransmitters Nitric oxide Nitrogen metabolism Pulmonary hypertension Extracorporeal membrane oxygenation Respiratory system Bronchopulmonary dysplasia Medicine Chemistry Health		FOR IMMEDIATE RELEASE FDA EXTENDS MARKETING EXCLUSIVITY FOR INOMAX® Clinton, NJ, January 5, 2011– Ikaria, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted INOMAX® (nitric oxide) for i Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 65,53 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.